Qyuns Therapeutics Co., Ltd.

Qyuns Therapeutics Co., Ltd. - PE Ratioverified

2509.HK

Price:

$15.01

Market Cap:

$2.89B

Qyuns Therapeutics Co., Ltd., a biotechnology company established in 2015 and headquartered in Taizhou, China, is focused on the discovery and clinical advancement of biologic therapies. Its primary mission is to address autoimmune and allergic diseases within the People's Republic of China. The company boasts a robust pipeline of investigational treatments. Its lead candidate, QX002N, an interleukin (IL)-17A inhibitor, is currently undergoing Phase III clinical trials for the management of ankylosing spondylitis and lupus nephritis. Another key asset, QX005N, a monoclonal antibody engineered to block IL-4Ra, has successfully concluded its Phase II clinical development. This compound targets...[Read more]

Industry

Biotechnology

IPO Date

2024-03-20

Stock Exchange

HKSE

Ticker

2509.HK

The PE Ratio as of July 2026 (TTM) for Qyuns Therapeutics Co., Ltd. (2509.HK) is 9.15

According to Qyuns Therapeutics Co., Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is 9.15. This represents a change of -151.40% compared to the average of -17.80 of the last 4 quarters.

Qyuns Therapeutics Co., Ltd. (2509.HK) Historical PE Ratio (quarterly & annually)

How has 2509.HK PE Ratio performed in the past?

The mean historical PE Ratio of Qyuns Therapeutics Co., Ltd. over the last ten years is -5.48. The current 9.15 PE Ratio has changed -16803.48% with respect to the historical average. Over the past ten years (40 quarters), 2509.HK's PE Ratio was at its highest in in the September 2025 quarter at 10.49. The PE Ratio was at its lowest in in the June 2025 quarter at -54.40.

Quarterly (TTM)
Annual

Average

-5.48

Median

-8.99

Minimum

-13.87

Maximum

12.31

Qyuns Therapeutics Co., Ltd. (2509.HK) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Qyuns Therapeutics Co., Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 12.59%

Maximum Annual PE Ratio = 12.31

Minimum Annual Increase = -371.78%

Minimum Annual PE Ratio = -13.87

Quarterly (TTM)
Annual
YearPE RatioChange
202512.31-371.78%
2024-4.53-49.59%
2023-8.99-35.19%
2022-13.8712.59%

Qyuns Therapeutics Co., Ltd. (2509.HK) Average PE Ratio

How has 2509.HK PE Ratio performed in the past?

The current PE Ratio of Qyuns Therapeutics Co., Ltd. (2509.HK) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-0.40

5-year avg

-5.48

10-year avg

-5.48

Qyuns Therapeutics Co., Ltd. (2509.HK) PE Ratio vs. Peers

How is 2509.HK’s PE Ratio compared to its peers?

Qyuns Therapeutics Co., Ltd.’s PE Ratio is greater than AIM Vaccine Co., Ltd. (-2.40), less than Viva Biotech Holdings (10.75), greater than Jacobio Pharmaceuticals Group Co., Ltd. (-21.47), greater than Ocumension Therapeutics (-23.22), less than Medtide Inc. (0), greater than TYK Medicines, Inc (-7.95), greater than ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (-5.67), greater than Antengene Corporation Limited (-8.86), less than Shanghai Kindly Medical Instruments Co., Ltd. (23.63), less than Modern Dental Group Limited (11.59),

Build a custom stock screener for Qyuns Therapeutics Co., Ltd. (2509.HK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Qyuns Therapeutics Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Qyuns Therapeutics Co., Ltd. (2509.HK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Qyuns Therapeutics Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Qyuns Therapeutics Co., Ltd.'s PE Ratio?

How is the PE Ratio calculated for Qyuns Therapeutics Co., Ltd. (2509.HK)?

What is the highest PE Ratio for Qyuns Therapeutics Co., Ltd. (2509.HK)?

What is the 3-year average PE Ratio for Qyuns Therapeutics Co., Ltd. (2509.HK)?

What is the 5-year average PE Ratio for Qyuns Therapeutics Co., Ltd. (2509.HK)?

How does the current PE Ratio for Qyuns Therapeutics Co., Ltd. (2509.HK) compare to its historical average?